中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 9
Sep.  2022
Turn off MathJax
Article Contents

The role of integrin α4 in the anti-liver fibrosis effect of the sticky sugar amino acid extract of Periplaneta americana

DOI: 10.3969/j.issn.1001-5256.2022.09.016
Research funding:

National Natural Science Foundation of China (82160801);

Yunnan Province Famous Doctor Project (Yunrenweifa〔2020〕20);

Yunnan Province Famous Doctor Project (RLMY20200015);

Yunnan Provincial Department of Science and Technology-Applied Basic Research Key Project (2017FE468 (-173));

Yunnan Provincial Department of Science and Technology-Applied Basic Research Joint Special Fund Project (2018FE001 (-214))

More Information
  • Corresponding author: LI Wu, liwukm@qq.com(ORCID: 0000-0002-1222-3629)
  • Received Date: 2022-01-09
  • Accepted Date: 2022-03-10
  • Published Date: 2022-09-20
  •   Objective  To investigate the mechanism of action of integrin α4 (ITGA4) in liver fibrosis based on the anti-liver fibrosis effect of sticky sugar amino acid (SSAA) in rats.  Methods  A rat model of liver fibrosis was induced by intraperitoneal injection of CCl4, and then colchicine and low-, middle-, and high-dose SSAA were used for intervention, with blank control group and SSAA group as control. After 12 weeks of experimental intervention, serum and liver samples were collected to measure the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and HE staining and Sirius Red staining were used to observe the pathological conditions of liver tissue; quantitative real-time PCR was used to measure the transcriptional level of ITGA4, integrin β1 (ITGB1), transforming growth factor-β1 (TGFβ1), alpha-smooth muscle actin (α-SMA), and TIMP2 in liver tissue; Western blot was used to measure the relative protein expression levels of ITGA4, ITGB1, TGFβ1, α-SMA, MMP2, TIMP1, and TIMP2; immunohistochemistry was used to observe the protein expression of TGFβ1 and α-SMA. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the least significant difference t-test was used for comparison between two groups.  Results  There were significant increases in AST and ALT in the CCl4 model group, and intervention with colchicine or low-, middle-, and high-dose SSAA reduced the levels of AST and ALT, with a significant difference between the CCl4 model group and the other groups (all P < 0.05). HE staining and Sirius Red staining showed disordered structure of hepatic lobules and an increase in collagen fibers in the CCl4 model group, and the structure of hepatic lobules was improved after intervention with colchicine or low-, middle-, and high-dose SSAA. The CCl4 model group had significantly higher transcriptional levels of ITGA4, TGFβ1, α-SMA, and TIMP2 than the other groups, and there were significant reductions in the transcriptional levels of each factor after intervention with colchicine or SSAA, with a significant difference between the CCl4 model group and the other groups (all P < 0.05). The CCl4 model group had significantly higher protein expression levels of ITGA4, TGFβ1, α-SMA, TIMP2, and TIMP1 and a significantly lower protein expression level of MMP2 than the other groups, and intervention with colchicine or SSAA inhibited the expression of ITGA4, TGFβ1, α-SMA, TIMP2, and TIMP1 and promoted the expression of MMP2. Immunohistochemistry showed that the CCl4 model group had significantly higher expression levels of TGFβ1 and α-SMA than the other groups, which was inhibited by intervention with colchicine or SSAA. The high-dose SSAA group had the most significant effect in reducing aminotransferases, improving lobular structure, and inhibiting the protein expression of liver fibrosis factors.  Conclusion  The high expression of ITGA4 in the liver is associated with the development of liver fibrosis, which is consistent with the increases in the expression of TGFβ1 and α-SMA. Inhibiting the expression of ITGA4 can provide more therapeutic targets for liver fibrosis and expand the anti-liver fibrosis mechanism of SSAA.

     

  • loading
  • [1]
    LI Y, PU S, LIU Q, et al. An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis[J]. J Control Release, 2019, 303: 77-90. DOI: 10.1016/j.jconrel.2019.04.022.
    [2]
    PULKKA OP, MPINDI JP, TYNNINEN O, et al. Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours[J]. J Cell Mol Med, 2018, 22(4): 2220-2230. DOI: 10.1111/jcmm.13502.
    [3]
    HINTERMANN E, CHRISTEN U. The many roles of cell adhesion molecules in hepatic fibrosis[J]. Cells, 2019, 8(12): 1503. DOI: 10.3390/cells8121503.
    [4]
    SFERRA R, VETUSCHI A, POMPILI S, et al. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis[J]. Pathol Res Pract, 2017, 213(1): 58-65. DOI: 10.1016/j.prp.2016.11.004.
    [5]
    SHAO T, CHEN Z, BELOV V, et al. [18F]-Alfatide PET imaging of integrin αvβ3 for the non-invasive quantification of liver fibrosis[J]. J Hepatol, 2020, 73(1): 161-169. DOI: 10.1016/j.jhep.2020.02.018.
    [6]
    BERNSMEIER C, van DER MERWE S, PÉRIANIN A. Innate immune cells in cirrhosis[J]. J Hepatol, 2020, 73(1): 186-201. DOI: 10.1016/j.jhep.2020.03.027.
    [7]
    SHAO MY, LAI Y. Effects of Ganlong Capsules combined with silibinin on the expression of Col-Ⅰ and TIMP-1 genes in liver tissue of hepatic fibrosis rats[J]. Advances in Veterinary Med, 2018, 39(10): 50-55. DOI: 10.16437/j.cnki.1007-5038.2018.10.010.

    邵明园, 赖泳. 肝龙胶囊联合水飞蓟宾对肝纤维化大鼠肝组织Col-Ⅰ和TIMP-1基因表达的影响[J]. 动物医学进展, 2018, 39(10): 50-55. DOI: 10.16437/j.cnki.1007-5038.2018.10.010.
    [8]
    HU YF. Efficacy and survival analysis of plasma exchange in patients with acute-on-chronic liver failure[D]. Zhengzhou: Zhengzhou University, 2020.

    呼怡菲. 血浆置换治疗慢加急性肝衰竭患者的疗效及生存分析[D]. 郑州: 郑州大学, 2020.
    [9]
    TSUCHIDA T, FRIEDMAN SL. Mechanisms of hepatic stellate cell activation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(7): 397-411. DOI: 10.1038/nrgastro.2017.38.
    [10]
    LACHOWSKI D, CORTES E, RICE A, et al. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis[J]. Sci Rep, 2019, 9(1): 7299. DOI: 10.1038/s41598-019-43759-6.
    [11]
    ZHOU J, LI R, ZHANG J, et al. Targeting interstitial myofibroblast-expressed integrin αvβ3 alleviates renal fibrosis[J]. Mol Pharm, 2021, 18(3): 1373-1385. DOI: 10.1021/acs.molpharmaceut.0c01182.
    [12]
    HUANG YZ, ZHAO L, ZHU Y, et al. Interrupting TGF-β1/CCN2/integrin-α5β1 signaling alleviates high mechanical-stress caused chondrocyte fibrosis[J]. Eur Rev Med Pharmacol Sci, 2021, 25(3): 1233-1241. DOI: 10.26355/eurrev_202102_24827.
    [13]
    STRUDWICK XL, ADAMS DH, PYNE NT, et al. Systemic delivery of anti-integrin αL antibodies reduces early macrophage recruitment, inflammation, and scar formation in murine burn wounds[J]. Adv Wound Care (New Rochelle), 2020, 9(12): 637-648. DOI: 10.1089/wound.2019.1035.
    [14]
    LIU W, SUN T, WANG Y. Integrin αvβ6 mediates epithelial-mesenchymal transition in human bronchial epithelial cells induced by lipopolysaccharides of Pseudomonas aeruginosa via TGF-β1-Smad2/3 signaling pathway[J]. Folia Microbiol (Praha), 2020, 65(2): 329-338. DOI: 10.1007/s12223-019-00728-w.
    [15]
    BONUS M, HÄUSSINGER D, GOHLKE H. Liver cell hydration and integrin signaling[J]. Biol Chem, 2021, 402(9): 1033-1045. DOI: 10.1515/hsz-2021-0193.
    [16]
    HIGHT-WARBURTON W, PARSONS M. Regulation of cell migration by α4 and α9 integrins[J]. Biochem J, 2019, 476(4): 705-718. DOI: 10.1042/BCJ20180415.
    [17]
    KUMMER C, PETRICH BG, ROSE DM, et al. A small molecule that inhibits the interaction of paxillin and alpha 4 integrin inhibits accumulation of mononuclear leukocytes at a site of inflammation[J]. J Biol Chem, 2010, 285(13): 9462-9469. DOI: 10.1074/jbc.M109.066993.
    [18]
    DAMMES N, GOLDSMITH M, RAMISHETTI S, et al. Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics[J]. Nat Nanotechnol, 2021, 16(9): 1030-1038. DOI: 10.1038/s41565-021-00928-x.
    [19]
    RAI RP, LIU Y, IYER SS, et al. Blocking integrin α4β7-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis[J]. J Hepatol, 2020, 73(5): 1013-1022. DOI: 10.1016/j.jhep.2020.05.047.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)  / Tables(2)

    Article Metrics

    Article views (450) PDF downloads(34) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return